Effect of cerebrospinal fluid from normal and Alzheimer's patients with different apolipoprotein E phenotypes on in vitro aggregation of amyloid beta-protein

Journal of the Neurological Sciences

Volumn 141, Issue 1-2, 1996, Pages 54-58

  Chauhan, Abha ^a   Pirttilä, Tuula ^b   Mehta, Pankaj ^a   Chauhan, Ved P S ^a   Wisniewski, Henryk M ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Amyloid beta protein; Apolipoprotein E; Cerebrospinal fluid

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN AGGREGATION;

EID: 0030587509     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00123-2     Document Type: Article

References (28)

1. Abraham, C.R., D.J. Selkoe and H.C. Potter (1988) Immunochemical identification of the serine protease inhibitor α 1 -antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501.
2. Carlsson, J., V.W. Armstrong, H. Reiber, K. Felgenhauer and D. Seidel (1991) Clinical relevance of the quantitation of apolipoprotein E in cerebrospinal fluid. Clin. Chim. Acta 196: 167-176.
3. Corder, E.H., A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines and M.A. PericakVance (1993) Gene dose of apolipoprotein E type 4 and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
4. Coria, F., E.M. Castano, F. Prelli, M. Larrondo-Lillo, S. VanDuinen, M.L. Shelanski and B. Frangione (1988) Isolation and characterizav tion of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab. Invest. 58: 454-457.
5. Diedrich, J.F., H. Minnigan, R.I. Carp, J.N. Whitaker, R. Race, W. Frey II, and A.T. Haase (1991) Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apov lipoprotein E and cathepsin in erythrocytes. J. Virol. 65: 4759-4768.
6. Frangione, B., T. Wisniewski, E.M. Castanol and J. Ghiso (1995) Amyloids, genes and chaperones in Alzheimer's Disease. In K. Iqbal et al. (Eds.). Research Advances in Alzheimer's Disease and Related Disorders, John Wiley and Sons, UK, pp 563-568.
7. Ghiso, J., E. Matsubara, A. Koudinov, T. Wisniewski and B. Frangione (1993) The cerebrospinal fluid soluble form of Alzheimer's amyloid β is complexed to SP-40, 40 (Apo J), an inhibitor of the complement membrane attack complex. Biochem. J. 293: 27-30.
8. Haass, C., M.G. Schlossmacher, A.Y. Hung, C. VigoPelfrey, A. Mellon, B.L. Ostaszewski, I. Lieberburg, E.H. Koo, D. Schenk, D.B. Teplow and D.J. Selkoe (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325.
9. Kida, E., N. Choi-Mura and K.E. Wisniewski (1995) Deposition of apolipoproteins E and J in senile plaques is topographically deterv mined in both Alzheimer's disease and Down's syndrome brain. Brain Res. 685: 211-216.
10. LaDu, M.J., M.T. Falduto, A.M. Manelli, C.A. Reardon, G.S. Getz, and D.E. Frail (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269: 23403-23406.
11. Jarett, J.T. and P.T. Lansbury, Jr., (1993) Seeding "One-Dimensional Crystallization" of Amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058.
12. Lehtimaki, T., T. Moilanen, J. Viikari, H.K. Akerblom, C. Ehnholm, T. Ronnemaa, J. Marniemi, G. Dahlen and T. Nikkari (1990) Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and six-year follow up study. J. Lipid Res. 31: 487-495.
13. Lehtimaki, T., T. Pirtillä, P.D. Mehta, H.M. Wisniewski, H. Frey and T. Nikkari (1995) Apoliprotein E (apoE) polymorphism and its influence on apoE concentration in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum. Gen. 95: 39-42.
14. LeVine, III, H. (1993) Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 2: 404-410.
15. Ma, J., A. Yee, B. Brewer, S. Das and H. Potter (1994). Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filament. Nature 372: 92-94.
16. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
17. Namba, Y., M. Tomonaya, H. Kawasaki, E. Otomo and K. Ikeda (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and Kuru plaque amyloid in Creutzfeld-Jacob disease. Brain Res. 541: 163-166.
18. Pirttilä, T., K.S. Kim, P.D. Mehta, H. Frey and H.M. Wisniewski (1994) Soluble amyloid β-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls J. Neurol. Sci. 127: 90-95.
19. Schmechel, D.E., A.M. Saunders, W.J. Strittmatter, B.J. Crain, C.M. Hulette, S.H. Joo, M.A. Pericak-Vance, D. Goldgaber and A.D. Roses (1993) Increased amyloid β-protein deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90: 9649-9653.
20. Schwarzman, A.L., L. Gregori, M.P. Vitek, S. Lyubski, W.J. Strittmatter, J.J. Enghilde, R. Bhasin, J. Silverman, K.H. Weisgraber, P.K. Coyle, M.G. Zagorski, J. Talafous, M. Eisenberg, A.M. Saunders, A.D. Roses and D. Goldgaber (1994) Transthyretin sequesters amyloid β-protein and prevents amyloid formation. Proc. Natl. Acad. Sci. U.S.A. 91: 8368-8372.
21. Seubert, P., C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schlossmacher, J. Whaley, C. Swindlehyurst, R. McCormack, R. Wolfert, D. Selkoe, I. Lieberburg and D. Schenk (1992) Isolation and quantitation of soluble Alzheimer's beta-peptide from biological fluids. Nature 359: 325-327.
22. Strittmatter, W.J., A.M. Saunders, M. Goedert, K.H. Weisgraber, L.M. Dong, R. Jakes, D.Y. Huang, M. Pericak-Vance, D. Schmechel and A.D. Roses (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 91, 11183-11186.
23. Strittmatter, W.J., K.H. Weisgraber, D.Y. Huang, L.M. Dong, G.S. Salvessen, M. Pericak-Vance, D. Schmechel, A.M. Saunders, D. Goldgaber and A.D. Roses (1993) Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90: 8098-8102.
24. Su, J.H., B.J. Cummings and C.W. Cotman (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neurosci 51: 801-813.
25. Wisniewski, T., E. Castano, J. Ghiso and B. Frangione (1993) Cerebrospinal fluid inhibits Alzheimer β-amyloid fibril formation in vitro. Ann. Neurol. 34: 631-633.
26. Wisniewski, T., E.M. Castano, A., Golabek, T. Vogel and B. Frangione (1994a) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145: 1030-1035.
27. Wisniewski, T., Ghiso, J. and Frangione, B. (1994b) Alzheimer's disease and soluble Aβ. Neurobiol. Aging 15: 143-152.
28. Wisniewski, H.M. and J. Wegiel (1994) Beta-protein fibrillogenesis and neuritic plaques. In D.B. Calne (Ed.). Neurodegenerative Diseases, W.B. Saunders Co., pp 83-95.